Alkem Labs approves FY26 results, recommends ₹10 dividend

Alkem Laboratories Limited's Board of Directors, at their meeting on May 28, 2026, approved the Standalone and Consolidated Audited Financial Results for the quarter and financial year ended March 31, 2026. The Board recommended a final dividend of ₹10 per equity share (of ₹2/- each) for FY26, subject to shareholder approval at the 52nd Annual General Meeting (AGM) scheduled for August 27, 2026. The record date for the dividend payment is August 7, 2026, with payment commencing September 1, 2026, if declared. Additionally, Mrs. Madhurima Singh was approved for re-appointment as an Executive Director for five years, effective December 20, 2026.